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In a recent article in this journal [1] I discussed the question 
of  poisoning in South Sudan in an attempt to generate 
information about the size of  the problem. As I pointed 
out from my experience in Uganda I was concerned about 
the occurrence of, and mortality from, poisoning with 
organophosphates. Seventy-one cases of  poisoning from 
organophosphates were reported from forty hospitals 
and health centres over a six months’ period with a 27% 
mortality. No other agent was associated with a death in 
this series (Table 1). 
Extrapolating these data to the whole country this 
could reflect 1,250 – 2,500 deaths per year. Worldwide 
there are thought to be around 
one million poisonings with a 
significant mortality. An estimate of  
mortality from self-poisoning from 
organophosphates in developing 
countries is around 200,000 each 
year [2]. Another study [3] from 
two hospitals in Kampala, Uganda, 
over a six months’ period in 2005 
reported 276 patients but, unlike my 
review, included patients poisoned 
with alcohol: 42.4% of  patients were 
poisoned with “agrochemicals”. The 
overall mortality was low at 1.4%.
What are organophosphates?
These compounds were first 
produced in the early 1800’s by 
the reaction between alcohol 
and phosphoric acid.  There are 
two main chemical groups.  The 
phosphorothioates (P=S) which include malathion, 
parathion, chlorpyrifos, diazinon, disulfoton, phosmet, 
fenitrothion and the phosphates (P=O) which include 
dichlorvos and trichlorfon.  
What is their toxic action?
They are easily absorbed through the gastro-intestinal 
and respiratory tracts and significantly through the skin. 
Their key action is to inhibit acetylcholinesterase which 
occurs especially in the nicotinic and muscarinic receptors 
of  nerve, muscle, and brain grey matter. Acetylcholine 
then accumulates at neuromuscular junctions causing 
depolarization of  skeletal muscle, resulting in weakness 
and fasciculations. In the central nervous system, neural 
transmission is disrupted. Reactivation (“recovery”) of  
this enzyme occurs very slowly but can be speeded up by 
a cholinesterase-reactivating agent such as pralidoxime. 
The time of  onset of  the toxicity and its duration 
vary enormously depending on the organophosphates 
implicated.  The phosphorothioates are more lipophilic and 
more chemically stable than the phosphates and must be 
biotransformed (activated) to become biologically active. 
This means that the onset of  features after exposure may 
be delayed and intoxication may be prolonged because 
of  storage in fat.  In contrast, phosphates are biologically 
active and therefore after exposure features may appear 
more quickly.
Recent research has indicated that the presence of  
solvents in commercial formulations may account for much 
of  their toxicity [4]. By reducing the toxicity to mammals 
in these agricultural preparations may significantly reduce 
the deaths from suicidal attempts.
What are their clinical effects?
The patient may have been exposed at the time of  
agricultural spraying of  crops in an enclosed space. 
Deliberate self-poisoning with an organophosphate is 
unusual in western countries but common in Africa.
The acute effects can appear within hours and 
depend on the way in which the person has been exposed: 
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Drugs / chemicals
Age up to 10 years Age over 10 years
Number (%) Deaths Number (%) Deaths (%)
Aspirin 1(3%) 0 2 (2%) 0
Batteries 2 (5%) 0 2 (2%) 0
Chloroquine 0 0 3 (3%) 0
Chlorpheniramine 0 0 1 (1%) 0
Diazepam 0 0 2 (2%) 0
Herbicide 0 0 1 (1%) 0
Kerosene 21 (55%) 0 1 (1%) 0
Organophosphate 8 (21%) 0 63 (66%) 19 (30%)
Paracetamol 4 (11%) 0 4 (4%) 0
Rat poison 1 (3%) 0 1 (1%) 0
Unknown 1 (3%) 0 15 (16%) 0
Totals 38 0 95 19 (20%)
Table 1. Reports of  poisoning in Uganda over six months from 40 health units
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inhalation, skin, ingestion (swallowing) and eye contact.
Inhalation:
• Chest tightness and wheezing,
• Cough,









• Nausea and vomiting,
• Diarrhoea (often watery),




• Constricted pupils (miosis), 
• Pain,
• Lacrimation (excess tears),
• Blurred vision.
Systemic features may include:
• Increased sweating,
• Uncontrolled defaecation and urination,
• Anxiety, restlessness and confusion,
• Muscle weakness, cramps and fasciculation,
• Ataxia and tremor,
• Headache and dizziness,
• Epileptics fits,
• Cardiac and respiratory failure,
• Glycosuria and hyperglycaemia.
The physical signs of  acute poisoning are as would 
be expected from excess acetylcholine action: pin-point 
pupils (constricted), marked sweating, muscle fasciculation 
and (especially proximal) muscle weakness. The neck 
flexor and eye (extra-ocular) muscles are particularly 
affected. If  the respiratory muscles are involved leading to 
respiratory failure then prognosis is poor. Bradycardia or 
tachycardia, cardiac dysrhythmias and marked hypotension 
may also occur. However there are later consequences of  
organophosphate poisoning as follows:
• Intermediate syndrome: Relapse after apparent 
resolution of  cholinergic symptoms has been reported in 
patients, particularly in those who have ingested highly 
lipophilic organophosphate insecticides, and is termed 
the “intermediate” syndrome.  Paralysis of  limb muscles, 
neck flexors and cranial nerves develops some 24-96 
hours after exposure and probably represent the nicotinic 
effects of  acetylcholine.
• Delayed neuropathy: organophosphate-
induced delayed neuropathy can also result rarely from 
acute exposure to some organophosphate insecticides 
(e.g. chlorpyrifos, dichlorvos, isofenphos, metamidophos, 
trichlorfon).  This delayed neuropathy is initiated by 
phosphorylation and subsequent aging of  at least 70% of  
neuropathy target esterase in peripheral nerves and occurs 
within hours of  poisoning. The features are characterised 
by distal degeneration of  some axons of  both the peripheral 
and central nervous systems occurring 1-4 weeks after 
single or short-term exposures.  Cramping muscle pain 
in the lower limbs, distal numbness and paraesthesiae 
occur, followed by progressive weakness, depression of  
deep tendon reflexes in the lower limbs and, in severe 
cases, in the upper limbs.  Signs include high-stepping gait 
associated with bilateral foot drop and, in severe cases, 
quadriplegia with foot and wrist drop as well as pyramidal 
signs.  In time, there might be significant recovery of  the 
peripheral nerve function but, depending on the degree of  
pyramidal involvement, spastic ataxia may be a permanent 
outcome.
diagnosis
This is usually obvious from the history (often 
obtained from attendants), symptoms and physical signs. 
It can be confirmed by measuring plasma or red blood cell 
acetylcholinesterase levels but such tests are highly unlikely 
to be available. Even if  they were available treatment must 
not await the results.
The differential diagnosis of  the long-term neurological 
features must include:





• Neuropathies caused by other toxic chemicals.
Management  
It is essential to protect of  all members of  the medical 
team from contact with any organophosphate on the 
patient’s clothing and from vomitus. Surgical gloves should 
be worn. After starting the stabilization and treatment 
the patient should be decontaminated by removing and 
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carefully disposing of  all clothing and then washing the 
patient with soap and water.
As with all patients at mortal risk resuscitation and 
stabilisation are priorities and the “ABC” should always 
be remembered: Airway, Breathing (ventilation) and 
Circulation. A note of  the Glasgow Coma Score is a useful 
baseline from which to monitor subsequent progress.
Oxygen should be given and intravenous (IV) access 
established. IV fluids should be administered according 
to observations with special attention to the risk of  the 
development of  pulmonary oedema. If  the latter occurs 
then the careful use of  IV furosamide may help.
There is little evidence that gastric lavage will improve 
outcomes. Indeed it may even worsen the outcome 
especially if  the airway is not adequately protected. If  the 
procedure is used it should only be carried out if  the toxic 
agent has been taken up to an hour before [5,6].
In the past activated charcoal has been given by mouth 
in an attempt to reduce absorption of  a toxic agent 
[7,8]. There appears to be little evidence of  benefit in 
organophosphate poisoning. It can be messy to administer 
and if  the patient is vomiting and perhaps has respiratory 
depression then there are added dangers to the airway.
In adults the routine use of  diazepam 5 – 10mg IV 
reduces anxiety and suppresses fits. It is important to note 
that phenothiazines (e.g chlorpromazine) should not be 
used for sedation as they have an anticholinesterase effect 
and so would make the situation worse. A careful watch 
of  respiratory function is essential when any form of  
sedation is given.
Atropine will block the muscurinic effects of  
acetylcholine. For an adult the dose is 1 – 3 mg IV and 
then repeated by doubling the dose every five minutes 
until there are signs of  a beneficial response. This is noted 
by the clearance of  bronchorrhoea and bronchospasm 
and the pulse rising above 80 / minute and systolic blood 
pressure above 80mmHg. Subsequent administration 
should be sufficient to maintain stability as noted by these 
observations. Some patients are resistant to the effects 
of  atropine and need large doses possibly up to 100mg 
in 24 hours. Too much atropine (atropine intoxication) 
is indicated by a tachycardia, dry mouth and skin and an 
abdominal ileus. For a child the initial dose of  atropine 
is 0.02 mg / kg. Atropinisation should be maintained for 
48 hours.
The use of  an oxime (e.g. pralidoxime chloride) 
has been suggested as beneficial if  the patient is treated 
at an early stage after taking the organophosphate. They 
work by reactivating cholinesterase. The loading dose is 
30 mg / kg given by IV injection over 30 minutes. If  
benefit follows, as reflected by improved muscle power 
and less fasciculation and convulsions and improved 
conscious level, then an infusion should be provided at 
8 – 10 mg/kg/hour and maintained until atropine has not 
been needed for up to 24 hours. The use of  an oxime 
should never replace the administration of  atropine. 
In my experience a supply of  an oxime has not been 
available where I have worked. However a recent review 
[9] of  the literature does not support this “standard” 
recommendation as beneficial, although it is possible 
that certain subgroups of  patients might benefit. Further 
research is needed to establish the best doses and for 
whom.
It is essential that all patients poisoned with an 
organophosphate are constantly and regularly monitored 
by the nursing and medical staff:
1. Hourly pulse, blood pressure and respiratory  
 rate charts.
2. Fluid balance charts.
3. Glasgow Coma Scale chart.
4. A baseline electrocardiogram recording could 
prove valuable later as may an initial assessment of  blood 
urea, creatinine and electrolytes although it is appreciated 
that facilities are often not available.
5. Any deterioration in respiratory function 
should be taken as an indication for possible artificial 
ventilation.
Post-recovery management
When a patient recovers from a self-poisoning event 
it is not the end of  the medical team’s responsibility. An 
assessment of  the patient’s psychosocial state is necessary 
to indicate an underlying psychiatric disorder and the risk 
of  repetition [10]. A sympathetic and non-judgmental 
approach must always be adopted.
Practice points
Self-poisoning with organophosphates is common • 
in developing countries with a high mortality.
Rapid initial assessment, resuscitation, stabilisation • 
and administration of  atropine is crucial.
The value of  oximes remains uncertain.• 
Close and careful monitoring of  the patient will  • 
alert the medical team to life-saving intervention.
The mortality can be reduced.• 
Post-recovery assessment and care are essential.• 
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a qUIz FOr OUr rEadErS
A woman aged 25 years was admitted because of  a post-
delivery problem following a prolonged labour. This picture 
was taken at the time of  the investigation:
(Photo credit: Brian Hancock)
What is the diagnosis?1. 
What is the significance of  the purple dye (arrowed) 2. 
appearing in the perineum?
What is the most likely cause of  the problem?3. 
What is the treatment?4. 
What is the social consequence before and after 5. 
successful management?
Answers on page 23
appreciation of Prof. Meo
SSMJ is saddened to hear of the recent death of Professor Giuseppe 
Meo of the Italian NGO Comitato Collaborazione Medica (CCM). 
Professor Meo was a surgeon who visited and worked over many 
years in remote rural areas of South Sudan starting in Wau in 1983 
up until last year. SSMJ recently published a paper by Professor 
Meo and his colleagues and we plan to publish his last one in a 
forthcoming issue. Professor Meo will be greatly missed by the many 
health professionals to whom he was a kind mentor and teacher, and 
by his patients.
